The Children’s Hospital of New York at NewYork-Presbyterian has been recognized as the #1 children’s hospital in New York City and a #1 children’s hospital in New York, according to U.S. News & World Report’s 2026-2027 “Best Children’s Hospitals” rankings.

With a shared commitment to exceptional care, the organizations are expanding access to outpatient rehabilitation services, opening nine new locations together across the New York metropolitan area in 2026.

A 4-year-old is among the first patients in the nation to receive the one-time treatment, which offers the promise of restored hearing for a rare form of congenital deafness

Earlier use of a targeted radionuclide therapy delays metastatic prostate cancer progression when administered as part of a trio of drugs, according to a phase 3 clinical trial led by Weill Cornell Medicine, NewYork-Presbyterian, Memorial Sloan Kettering Cancer Center and investigators at several other institutions worldwide.

Dr. Angela Kadenhe-Chiweshe, an accomplished pediatric surgeon and leader in complex pediatric surgery, has been appointed chief of the Division of Pediatric Surgery at NewYork-Presbyterian Komansky Children’s Hospital of Children’s Hospital of New York and Weill Cornell Medicine, effective July 1.

U.S. News & World Report recognizes NewYork-Presbyterian Hospital for excellence, with eight specialties ranked in the top five and ten specialties in the top ten, nationally.

NewYork-Presbyterian today announced its adoption of Signal 1's AI Management System (AIMS) and plans to work closely with the technology company to support the safe management and monitoring of artificial intelligence technologies across the institution — from tools that help detect cancer and structural heart disease to applications that support discharge planning and clinical documentation.

Weill Cornell Medicine investigators have developed a new AI-based method to assess patients with a form of blood cancer called myelodysplastic neoplasms.